Publications by authors named "Enzo Terreno"

Introduction: High grade gliomas are characterized by a very poor prognosis due to fatal relapses after surgery. Current chemotherapy is only a palliative care, while potential drug candidates are limited by poor overcoming of the blood-brain barrier.

Aims: A suitable chemotherapeutic approach should be engineered to overcome both the altered blood-brain barrier in the glioma site, as well as the intact one in the brain adjacent to tumor zone, and to target the multiple factors influencing glioma proliferation, differentiation, migration, and angiogenesis.

View Article and Find Full Text PDF

This work presents a group of high-quality hydrophilic and negatively charged coated, iron oxide magnetic nanoparticles (MNPs) that have been prepared using a microwave-ultrasound-assisted protocol, and demonstrates the great impact that the synthetic strategy has on the resulting MNPs. The different coatings tested, including citric acid, carboxymethyl dextran and β-cyclodextrin (βCD)/citric acid have been compared and have shown good dispersibility and stability. The ability of βCD to maintain the inclusive properties of the coated MNPs has been proven as well as their cytocompatibility.

View Article and Find Full Text PDF
Article Synopsis
  • The research explores a new way to visualize nanoparticles in medical imaging using MRI and MRS techniques, specifically focusing on detecting natural proton signals in commonly used nanosystems.
  • Three different nanosystems (lipid-based micelles, liposomes, and perfluorocarbon-based nanoemulsions) were created and characterized, with the perfluorocarbon-based nanoemulsion showing the best performance in signal detection.
  • This method allows for the detection of nanoparticles without needing additional probes, indicating a significant advancement in non-invasive imaging for diagnostics and treatments in biomedical applications.
View Article and Find Full Text PDF

Macrocyclic chelators play a central role in medical imaging and nuclear medicine owing to their unparalleled metal cation coordination abilities. Their functionalization by fluorinated groups is an attractive design, to combine their properties with those of F for Positron Emission Tomography (PET) or natural F for Magnetic Resonance Imaging (MRI), and access potential theranostic or smart medical imaging probes. For the first time, a compact fluorinated macrocyclic architecture has been synthesized, based on a cyclen chelator bearing additional pyridine coordinating units and simple methyltrifluoroborate prosthetic groups.

View Article and Find Full Text PDF
Article Synopsis
  • Photodynamic therapy (PDT) is a treatment that uses light and a special drug called a photosensitiser to target diseases like prostate cancer, focusing on selective uptake by diseased tissues.* -
  • This study introduces two silicon(IV) phthalocyanine compounds, SiPc-PQ(PSMAi) and SiPc-OSi(PSMAi), which are designed to enhance PDT effectiveness; they differ in their chemical link connecting the PSMA inhibitor to the silicon atom.* -
  • The findings show that SiPc-PQ(PSMAi) has superior properties in terms of oxygen generation, fluorescence, stability, and specific toxicity towards prostate cancer cells with PSMA, making it a promising
View Article and Find Full Text PDF

The certification of cosmetic products has always been a prominent concern. Here, we have developed a pH sensor and applied it in the field of cosmetic safety. Initially, we designed two probes, CH with aggregation-induced emission (AIE) effect and the near-infrared fluorophore derivative CYTYR.

View Article and Find Full Text PDF

The self-assembly of peptides and peptide analogues may be exploited to develop platforms for different biomedical applications, among which CEST-MRI (chemical exchange saturation transfer magnetic resonance imaging) represents one of the most attractive techniques to be explored as a novel metal-free contrast approach in imaging acquisitions. A lysine-containing peptide sequence (LIVAGK-NH, named K2) was thus modified by insertion, at the N-terminus, of a peptide nucleic acid (PNA) base, leading to a primary amine suitable for the signal generation. a-K2, c-K2, g-K2 and t-K2 peptides were synthesized and characterized.

View Article and Find Full Text PDF
Article Synopsis
  • - A new CT imaging agent made from bismuth was developed using a straightforward synthesis method.
  • - Researchers tested the agent for stability, toxicity, and performance in CT imaging.
  • - In vivo imaging was conducted with various doses, and the effectiveness of the 1.2 mmol/kg dose was compared to the established CT agent, iopamidol, at the same dose.
View Article and Find Full Text PDF

This paper describes a novel nanoformulation for dual MRI/US in vivo monitoring of drug delivery/release. The nanosystem was made of a perfluoropentane core coated with phospholipids stabilized by glycol chitosan crosslinked with triphosphate ions, and it was co-loaded with the prodrug prednisolone phosphate (PLP) and the structurally similar MRI agent Gd-DTPAMA-CHOL. Importantly, the in vitro release of PLP and Gd-DTPAMA-CHOL from the nanocarrier showed similar profiles, validating the potential impact of the MRI agent as an imaging reporter for the drug release.

View Article and Find Full Text PDF

Peptide-based hydrogels have been recently investigated as materials for biomedical applications like tissue engineering and delivery of drugs and imaging agents. Among the synthetic peptide hydrogelators, the cationic hexapeptides Ac-K1 and Ac-K2 were proposed as scaffolds for bioprinting applications. Here, we report the formulation of Ac-K1 and Ac-K2 hydrogels loaded with iopamidol, an iodinated contrast agent clinically approved for X-ray computed tomography, and more recently identified as an efficient CEST-MRI probe.

View Article and Find Full Text PDF
Article Synopsis
  • * Lestaurtinib, a compound that inhibits CITK effectively, was tested on various MB cell lines and showed that it disrupts cell division and growth while causing DNA damage and activating cancer-related cellular responses.
  • * The treatment with Lestaurtinib not only decreased tumor size but also improved survival rates in a mouse model, indicating its potential as a viable option for MB therapy beyond its original applications.
View Article and Find Full Text PDF
Article Synopsis
  • - The text discusses a new type of nanogels made from a chitosan matrix, which are stabilized by a Mn-t-CDTA derivative and serve dual purposes as both a contrast medium and a cross-linking agent.
  • - These nanogels offer significant advantages over traditional Gd(III) chelates, showing seven times higher relaxivity in clinical settings and maintaining high stability under physiological conditions.
  • - They demonstrate effective accumulation in tumors with optimal contrast visible at 24 hours post-injection, making them potential candidates for advanced MRI imaging in medical applications.
View Article and Find Full Text PDF

Drug repurposing is a valuable strategy for rare diseases. Sickle cell disease (SCD) is a rare hereditary hemolytic anemia accompanied by acute and chronic painful episodes, most often in the context of vaso-occlusive crisis (VOC). Although progress in the knowledge of pathophysiology of SCD have allowed the development of new therapeutic options, a large fraction of patients still exhibits unmet therapeutic needs, with persistence of VOCs and chronic disease progression.

View Article and Find Full Text PDF

Background: Breast cancer is the most common malignancy in women, with high morbidity and mortality. Molecular alterations in breast cancer involve the expression or upregulation of various molecular targets that can be used for diagnostic nuclear medicine imaging and radiopharmaceutical treatment. Theragnostics is based on the binding of radionuclides to molecular targets.

View Article and Find Full Text PDF

Ovarian cancer (OC) is characterised by the highest mortality of all gynaecological malignancies, frequent relapses, and the development of resistance to drug therapy. Sonodynamic therapy (SDT) is an innovative anticancer approach that combines a chemical/drug (sonosensitizer) with low-intensity ultrasound (US), which are both harmless per sé, with the sonosensitizer being acoustically activated, thus yielding localized cytotoxicity often via reactive oxygen species (ROS) generation. Doxorubicin (Doxo) is a potent chemotherapeutic drug that has also been recommended as a first-line treatment against OC.

View Article and Find Full Text PDF

Development of the field of magnetic resonance imaging (MRI) chemical exchange saturation transfer (CEST) contrast agents is hampered by the limited sensitivity of the technique. In water, the high proton concentration allows for an enormous amplification of the exchanging proton pool. However, the H CEST in water implies that the number of nuclear spins of the CEST-generating species has to be in the millimolar range.

View Article and Find Full Text PDF
Article Synopsis
  • A significant percentage of prostate cancer patients end up with positive tumor margins after surgery, but combining fluorescence-guided surgery (FGS) with photodynamic therapy (PDT) may improve tumor removal and treatment.* -
  • Researchers developed a PSMA-targeted Near InfraRed Fluorescent probe (IRDye700DX-PSMA) that effectively binds to prostate cancer cells, allowing for precise imaging and delineation of tumor margins during surgery.* -
  • The study found that this new probe not only effectively visualized tumors but also demonstrated the ability to reduce cancer cell viability through PDT, suggesting it may enhance both the detection and treatment of prostate cancer.*
View Article and Find Full Text PDF
Article Synopsis
  • The chemical exchange saturation transfer (CEST) technique has faced challenges with low sensitivity, prompting research into supramolecular and nanosized agents that enhance the number of mobile spins.
  • The development of compartmentalized agents, featuring a semipermeable barrier, allows these systems to serve as carriers for diverse CEST probes and to function as CEST probes themselves, improving application versatility.
  • The introduction of lipoCEST agents, which achieve high sensitivity, along with larger natural vesicular systems, advances the sensitivity limits of CEST agents, potentially leading to clinical applications and theranostic innovations.
View Article and Find Full Text PDF

The development of multimodal imaging techniques such as positron emission tomography (PET) and magnetic resonance imaging (MRI) allows the contemporary obtaining of metabolic and morphological information. To fully exploit the complementarity of the two imaging modalities, the design of probes displaying radioactive and magnetic properties at the same time could be very beneficial. In this regard, transition metals offer appealing options, with manganese representing an ideal candidate.

View Article and Find Full Text PDF

Breast cancer is one of the most common malignancies in women, with high morbidity and mortality rates. In breast cancer, the use of novel radiopharmaceuticals in nuclear medicine can improve the accuracy of diagnosis and staging, refine surveillance strategies and accuracy in choosing personalized treatment approaches, including radioligand therapy. Nuclear medicine thus shows great promise for improving the quality of life of breast cancer patients by allowing non-invasive assessment of the diverse and complex biological processes underlying the development of breast cancer and its evolution under therapy.

View Article and Find Full Text PDF

Nanogels (NGs) obtained by electrostatic interactions between chitosan and hyaluronic acid and comprising paramagnetic Gd chelates are gaining increasing attention for their potential application in magnetic resonance bioimaging. Herein, the macrocyclic complexes [Gd(DOTP)], lacking metal-bound water molecules ( = 0), were confined or used as a cross-linker in this type of NG. Unlike the typical behavior of Gd complexes with = 0, a remarkable relaxivity value of 78.

View Article and Find Full Text PDF

Novel Mn(II)-based nanoprobes were rationally designed as high contrast enhancing agents for magnetic resonance imaging (MRI) and obtained by anchoring a Mn(II)-CDTA derivative to the surface of organo-modified silica nanoparticles (SiNPs). Large payloads of paramagnetic metal-chelates have been immobilized on biocompatible SiNPs with spherical shape and narrow size distribution of 80-90 nm, resulting in a relaxivity gain of 250% at clinical fields (0.5 T) as compared to the free chelate.

View Article and Find Full Text PDF
Article Synopsis
  • Lung cancer is the leading cause of cancer-related deaths and is often diagnosed at advanced stages (III or IV), but new targeted therapies and immunotherapy have improved prognosis.
  • Treatment success is influenced by tumor biology and its interaction with the immune microenvironment, although reliable biomarkers for immune checkpoint inhibitors are still lacking.
  • The paper reviews ongoing research into predictive factors for treatment response, including both laboratory and advanced molecular imaging techniques that leverage technological and bioinformatics advancements.
View Article and Find Full Text PDF

D-Glucose and 3-O-Methyl-D-glucose (3OMG) have been shown to provide contrast in magnetic resonance imaging-chemical exchange saturation transfer (MRI-CEST) images. However, a systematic comparison between these two molecules has yet to be performed. The current study deals with the assessment of the effect of pH, saturation power level (B ) and magnetic field strength (B ) on the MRI-CEST contrast with the aim of comparing the in vivo CEST contrast detectability of these two agents in the glucoCEST procedure.

View Article and Find Full Text PDF
Article Synopsis
  • Triple-negative breast cancer (TNBC) patients often struggle with poor outcomes after chemotherapy, prompting the exploration of MRI-glucoCEST as a potentially more accurate and less harmful method for monitoring treatment response compared to traditional [F]F-FDG-PET/CT imaging.* -
  • In a study using a murine model, mice treated with doxorubicin showed significant tumor growth reduction and detectable metabolic changes through glucoCEST imaging, whereas [F]F-FDG uptake exhibited no variation.* -
  • The results suggest that glucoCEST imaging may be a more sensitive tool for tracking metabolic responses to therapy in TNBC, but further research is necessary to validate its effectiveness across different cancer types and treatment modalities
View Article and Find Full Text PDF